| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sjogren's Syndrome | 24 | 2026 | 278 | 4.400 |
Why?
|
| Antigens, Bacterial | 15 | 2025 | 166 | 4.180 |
Why?
|
| Bacterial Toxins | 15 | 2025 | 276 | 3.750 |
Why?
|
| Anthrax | 10 | 2025 | 92 | 2.950 |
Why?
|
| Autoantigens | 17 | 2026 | 216 | 2.760 |
Why?
|
| Ribonucleoproteins | 16 | 2026 | 155 | 2.750 |
Why?
|
| Bacillus anthracis | 10 | 2025 | 154 | 2.640 |
Why?
|
| Antibodies, Bacterial | 10 | 2020 | 103 | 2.360 |
Why?
|
| Anthrax Vaccines | 10 | 2020 | 35 | 2.350 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2026 | 117 | 1.930 |
Why?
|
| B-Lymphocytes | 12 | 2026 | 287 | 1.930 |
Why?
|
| Antibodies, Neutralizing | 5 | 2020 | 74 | 1.750 |
Why?
|
| Lupus Erythematosus, Systemic | 13 | 2026 | 997 | 1.440 |
Why?
|
| Salivary Glands, Minor | 4 | 2021 | 21 | 1.340 |
Why?
|
| Immunoglobulin G | 15 | 2026 | 276 | 1.300 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2026 | 88 | 1.240 |
Why?
|
| Autoantibodies | 13 | 2026 | 486 | 1.180 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2026 | 35 | 1.150 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2016 | 48 | 1.140 |
Why?
|
| Autoimmunity | 9 | 2021 | 158 | 1.100 |
Why?
|
| Epitopes, B-Lymphocyte | 4 | 2013 | 24 | 0.950 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2023 | 46 | 0.950 |
Why?
|
| Toll-Like Receptors | 3 | 2012 | 22 | 0.930 |
Why?
|
| Mice | 31 | 2021 | 4845 | 0.890 |
Why?
|
| Animals | 37 | 2026 | 10756 | 0.840 |
Why?
|
| Antibodies, Antinuclear | 10 | 2023 | 183 | 0.820 |
Why?
|
| Humans | 51 | 2026 | 29078 | 0.790 |
Why?
|
| Epitopes | 6 | 2021 | 185 | 0.780 |
Why?
|
| Immunity, Humoral | 5 | 2020 | 48 | 0.780 |
Why?
|
| Macrophages | 5 | 2024 | 306 | 0.760 |
Why?
|
| Antibody Specificity | 6 | 2021 | 114 | 0.720 |
Why?
|
| Interferon Type I | 3 | 2017 | 56 | 0.710 |
Why?
|
| Middle Aged | 21 | 2026 | 7458 | 0.670 |
Why?
|
| Female | 31 | 2026 | 15740 | 0.660 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.640 |
Why?
|
| Neutralization Tests | 7 | 2020 | 34 | 0.620 |
Why?
|
| Adult | 21 | 2026 | 8080 | 0.620 |
Why?
|
| Lymphocyte Activation | 8 | 2026 | 214 | 0.600 |
Why?
|
| Neutrophils | 2 | 2025 | 185 | 0.590 |
Why?
|
| Phagocytosis | 1 | 2019 | 81 | 0.570 |
Why?
|
| Immune Tolerance | 7 | 2015 | 52 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 1672 | 0.540 |
Why?
|
| Male | 22 | 2026 | 14049 | 0.540 |
Why?
|
| c-Mer Tyrosine Kinase | 3 | 2024 | 13 | 0.530 |
Why?
|
| RNA | 5 | 2021 | 111 | 0.520 |
Why?
|
| Dendritic Cells | 2 | 2016 | 144 | 0.500 |
Why?
|
| Adipose Tissue | 1 | 2017 | 197 | 0.470 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 514 | 0.460 |
Why?
|
| Salivary Glands | 3 | 2025 | 58 | 0.460 |
Why?
|
| Interleukin-6 | 2 | 2014 | 198 | 0.450 |
Why?
|
| Ribosomes | 1 | 2015 | 32 | 0.440 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 20 | 0.440 |
Why?
|
| Nephritis | 1 | 2014 | 10 | 0.430 |
Why?
|
| ADAM Proteins | 1 | 2015 | 103 | 0.430 |
Why?
|
| Lymphocytes | 1 | 2014 | 91 | 0.410 |
Why?
|
| Autoimmune Diseases | 6 | 2026 | 170 | 0.400 |
Why?
|
| Case-Control Studies | 4 | 2025 | 740 | 0.400 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 10 | 0.390 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1522 | 0.370 |
Why?
|
| Lung | 2 | 2014 | 385 | 0.370 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 645 | 0.360 |
Why?
|
| T-Lymphocytes | 4 | 2025 | 285 | 0.360 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2015 | 216 | 0.360 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2012 | 35 | 0.360 |
Why?
|
| Aged | 9 | 2026 | 5627 | 0.360 |
Why?
|
| Signal Transduction | 5 | 2021 | 1482 | 0.330 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2008 | 30 | 0.330 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2013 | 62 | 0.320 |
Why?
|
| Apoptosis | 4 | 2021 | 781 | 0.320 |
Why?
|
| Spleen | 2 | 2007 | 114 | 0.310 |
Why?
|
| Aging | 1 | 2017 | 1029 | 0.310 |
Why?
|
| Clonal Anergy | 2 | 2008 | 11 | 0.310 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 16 | 0.310 |
Why?
|
| Kidney Glomerulus | 1 | 2009 | 15 | 0.310 |
Why?
|
| Complement C3 | 1 | 2009 | 21 | 0.300 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2009 | 20 | 0.300 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 149 | 0.300 |
Why?
|
| Young Adult | 6 | 2020 | 2855 | 0.300 |
Why?
|
| Enterotoxins | 2 | 2026 | 26 | 0.290 |
Why?
|
| HLA-DQ Antigens | 1 | 2007 | 25 | 0.270 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 239 | 0.270 |
Why?
|
| HLA-DR Antigens | 1 | 2007 | 29 | 0.270 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2007 | 24 | 0.260 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 31 | 0.260 |
Why?
|
| Immunoglobulin M | 2 | 2026 | 31 | 0.260 |
Why?
|
| Albuminuria | 1 | 2007 | 23 | 0.260 |
Why?
|
| B-Cell Activating Factor | 1 | 2007 | 32 | 0.260 |
Why?
|
| Biopsy | 2 | 2017 | 208 | 0.250 |
Why?
|
| Mice, Inbred Strains | 3 | 2013 | 62 | 0.250 |
Why?
|
| Complementarity Determining Regions | 1 | 2025 | 11 | 0.240 |
Why?
|
| Prognosis | 3 | 2017 | 815 | 0.240 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 381 | 0.240 |
Why?
|
| Superantigens | 1 | 2005 | 6 | 0.240 |
Why?
|
| Transcriptome | 2 | 2021 | 243 | 0.230 |
Why?
|
| Blood Coagulation Disorders | 1 | 2025 | 28 | 0.230 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 499 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 118 | 0.220 |
Why?
|
| Sepsis | 1 | 2025 | 88 | 0.220 |
Why?
|
| Flow Cytometry | 3 | 2015 | 292 | 0.220 |
Why?
|
| Fatigue | 1 | 2025 | 66 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 257 | 0.220 |
Why?
|
| Cell Polarity | 2 | 2019 | 22 | 0.220 |
Why?
|
| Blood Coagulation | 1 | 2025 | 120 | 0.210 |
Why?
|
| Mutation | 2 | 2008 | 873 | 0.210 |
Why?
|
| Cell Line | 5 | 2023 | 701 | 0.210 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2024 | 6 | 0.210 |
Why?
|
| Epitope Mapping | 3 | 2021 | 38 | 0.210 |
Why?
|
| Antigens, Nuclear | 1 | 2003 | 22 | 0.200 |
Why?
|
| Peptidoglycan | 1 | 2024 | 47 | 0.200 |
Why?
|
| Cell Wall | 1 | 2024 | 68 | 0.200 |
Why?
|
| Oxygen | 2 | 2021 | 237 | 0.200 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 417 | 0.190 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 381 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 477 | 0.190 |
Why?
|
| Endothelium, Vascular | 1 | 2025 | 334 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2019 | 1022 | 0.180 |
Why?
|
| Antigen-Presenting Cells | 3 | 2023 | 33 | 0.180 |
Why?
|
| Molecular Sequence Data | 7 | 2010 | 1057 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 17 | 0.180 |
Why?
|
| Conserved Sequence | 2 | 1999 | 55 | 0.170 |
Why?
|
| Cytoplasm | 2 | 2021 | 57 | 0.170 |
Why?
|
| Mitochondria | 1 | 2025 | 418 | 0.170 |
Why?
|
| Nucleic Acid Conformation | 2 | 1999 | 90 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 94 | 0.170 |
Why?
|
| RNA, Small Cytoplasmic | 5 | 2000 | 63 | 0.170 |
Why?
|
| Antibody-Producing Cells | 2 | 2018 | 15 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 270 | 0.170 |
Why?
|
| Cell Nucleus | 1 | 2021 | 138 | 0.170 |
Why?
|
| Thymus Gland | 2 | 2015 | 55 | 0.170 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 82 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2015 | 668 | 0.160 |
Why?
|
| Cell Communication | 1 | 2021 | 68 | 0.160 |
Why?
|
| Turkey | 1 | 2020 | 10 | 0.160 |
Why?
|
| Base Sequence | 5 | 2007 | 589 | 0.160 |
Why?
|
| Antigen Presentation | 2 | 2015 | 82 | 0.160 |
Why?
|
| Nucleic Acids | 2 | 2012 | 10 | 0.150 |
Why?
|
| Immunization | 3 | 2021 | 133 | 0.150 |
Why?
|
| Receptors, Vitronectin | 1 | 2019 | 4 | 0.150 |
Why?
|
| Vertebrates | 2 | 1999 | 18 | 0.150 |
Why?
|
| Protein S | 1 | 2019 | 26 | 0.150 |
Why?
|
| Interleukin-4 | 1 | 2019 | 23 | 0.150 |
Why?
|
| Milk Proteins | 1 | 2019 | 19 | 0.150 |
Why?
|
| Pandemics | 1 | 2020 | 206 | 0.150 |
Why?
|
| Antigens, Surface | 1 | 2019 | 39 | 0.150 |
Why?
|
| Coculture Techniques | 1 | 2019 | 55 | 0.150 |
Why?
|
| ROC Curve | 2 | 2017 | 144 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2019 | 63 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2021 | 267 | 0.140 |
Why?
|
| Cyclic AMP | 1 | 2019 | 96 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2019 | 74 | 0.140 |
Why?
|
| Sex Factors | 2 | 2017 | 473 | 0.140 |
Why?
|
| Biomarkers | 2 | 2023 | 787 | 0.140 |
Why?
|
| Age Factors | 2 | 2017 | 740 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2021 | 876 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 336 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2017 | 95 | 0.130 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 612 | 0.130 |
Why?
|
| Phenotype | 2 | 2021 | 688 | 0.130 |
Why?
|
| Peptides | 4 | 2013 | 297 | 0.130 |
Why?
|
| Linear Models | 1 | 2017 | 204 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 56 | 0.130 |
Why?
|
| Fibrosis | 1 | 2017 | 143 | 0.130 |
Why?
|
| RNA Polymerase III | 1 | 1996 | 5 | 0.130 |
Why?
|
| Lymphocyte Subsets | 1 | 2016 | 8 | 0.120 |
Why?
|
| Logistic Models | 1 | 2017 | 415 | 0.120 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 19 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 35 | 0.120 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 22 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 485 | 0.120 |
Why?
|
| CD4 Antigens | 2 | 2023 | 19 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 94 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 468 | 0.120 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 67 | 0.120 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2015 | 2 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 344 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2014 | 21 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2014 | 36 | 0.110 |
Why?
|
| ADAMTS13 Protein | 1 | 2015 | 126 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 114 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 73 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 328 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 465 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2023 | 61 | 0.100 |
Why?
|
| Genome, Human | 1 | 2023 | 70 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 38 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2013 | 77 | 0.100 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2012 | 7 | 0.100 |
Why?
|
| Mice, Inbred A | 2 | 2012 | 14 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2014 | 153 | 0.090 |
Why?
|
| Furin | 1 | 2012 | 4 | 0.090 |
Why?
|
| Antitoxins | 1 | 2012 | 13 | 0.090 |
Why?
|
| Lethal Dose 50 | 1 | 2011 | 14 | 0.090 |
Why?
|
| DNA | 2 | 2012 | 378 | 0.090 |
Why?
|
| Cytokines | 2 | 2026 | 456 | 0.090 |
Why?
|
| Species Specificity | 1 | 2011 | 196 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2013 | 233 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2011 | 77 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 151 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2021 | 259 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2025 | 83 | 0.080 |
Why?
|
| Calcium Signaling | 2 | 2008 | 72 | 0.080 |
Why?
|
| Toxoplasma | 1 | 2010 | 33 | 0.080 |
Why?
|
| Nucleosomes | 1 | 2009 | 18 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2009 | 74 | 0.080 |
Why?
|
| Histones | 1 | 2009 | 96 | 0.070 |
Why?
|
| Cholesterol | 2 | 2007 | 204 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2018 | 827 | 0.070 |
Why?
|
| Lymphopoiesis | 1 | 2009 | 22 | 0.070 |
Why?
|
| Myeloid Cells | 1 | 2009 | 27 | 0.070 |
Why?
|
| Antibodies | 1 | 2009 | 125 | 0.070 |
Why?
|
| Gene Expression | 2 | 2007 | 417 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 284 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2021 | 453 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 697 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 471 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 22 | 0.070 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2007 | 14 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 1999 | 112 | 0.070 |
Why?
|
| Peptide Nucleic Acids | 1 | 2007 | 1 | 0.070 |
Why?
|
| HLA-DRB1 Chains | 1 | 2007 | 33 | 0.070 |
Why?
|
| Nephrosis, Lipoid | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glomerular Basement Membrane | 1 | 2007 | 3 | 0.070 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 15 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 13 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 40 | 0.070 |
Why?
|
| Iguanas | 2 | 1999 | 3 | 0.070 |
Why?
|
| Podocytes | 1 | 2007 | 13 | 0.070 |
Why?
|
| Creatinine | 1 | 2007 | 60 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 82 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2021 | 57 | 0.060 |
Why?
|
| Oncogenes | 1 | 2007 | 34 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 681 | 0.060 |
Why?
|
| Haplotypes | 1 | 2007 | 289 | 0.060 |
Why?
|
| Models, Immunological | 1 | 2006 | 22 | 0.060 |
Why?
|
| RNA Stability | 1 | 2006 | 28 | 0.060 |
Why?
|
| Interleukin-7 | 1 | 2026 | 14 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2007 | 118 | 0.060 |
Why?
|
| Retina | 1 | 2010 | 445 | 0.060 |
Why?
|
| Hybridomas | 1 | 2006 | 17 | 0.060 |
Why?
|
| Immunodominant Epitopes | 1 | 2006 | 13 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 60 | 0.060 |
Why?
|
| Mucin-1 | 1 | 2006 | 36 | 0.060 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2005 | 14 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2006 | 68 | 0.060 |
Why?
|
| Complement Activation | 1 | 2025 | 27 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2021 | 46 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2026 | 103 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2005 | 44 | 0.060 |
Why?
|
| Papio | 1 | 2025 | 81 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2006 | 103 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 130 | 0.060 |
Why?
|
| Kidney | 1 | 2007 | 289 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 115 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2005 | 43 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2005 | 163 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 278 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2025 | 190 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 405 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 197 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 490 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2025 | 216 | 0.050 |
Why?
|
| Vimentin | 1 | 2023 | 28 | 0.050 |
Why?
|
| ADAM17 Protein | 1 | 2021 | 13 | 0.040 |
Why?
|
| Thymocytes | 1 | 2021 | 13 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 50 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 40 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 101 | 0.040 |
Why?
|
| Saliva | 1 | 2021 | 96 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 25 | 0.040 |
Why?
|
| Disulfides | 1 | 2021 | 34 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 15 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2021 | 130 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 202 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 87 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 153 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 484 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 686 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2000 | 128 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 213 | 0.040 |
Why?
|
| Polymers | 1 | 2021 | 118 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 557 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 156 | 0.040 |
Why?
|
| Adolescent | 3 | 2016 | 3233 | 0.040 |
Why?
|
| Trout | 1 | 1999 | 1 | 0.040 |
Why?
|
| Ducks | 1 | 1999 | 3 | 0.040 |
Why?
|
| Anura | 1 | 1999 | 4 | 0.040 |
Why?
|
| Automation | 1 | 1999 | 21 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1999 | 73 | 0.040 |
Why?
|
| United States | 2 | 2016 | 2252 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 281 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 70 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 1997 | 14 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 1997 | 12 | 0.030 |
Why?
|
| Herpesviridae Infections | 1 | 1997 | 17 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 1997 | 45 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1997 | 10 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 389 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 48 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 14 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1997 | 212 | 0.030 |
Why?
|
| Phylogeny | 1 | 1999 | 496 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 357 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 1996 | 95 | 0.030 |
Why?
|
| Chromosomes | 1 | 1996 | 59 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 166 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 13 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1995 | 48 | 0.030 |
Why?
|
| Xenopus | 1 | 1995 | 28 | 0.030 |
Why?
|
| Lip | 1 | 2014 | 10 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 26 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 100 | 0.020 |
Why?
|
| Consensus | 1 | 2013 | 76 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2012 | 10 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 81 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2013 | 247 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 34 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2012 | 20 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 59 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 18 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 902 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2010 | 11 | 0.020 |
Why?
|
| Bioterrorism | 1 | 2010 | 28 | 0.020 |
Why?
|
| B7-H1 Antigen | 1 | 2010 | 38 | 0.020 |
Why?
|
| Leukocytes | 1 | 2010 | 72 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2010 | 67 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2009 | 12 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Immunoglobulin D | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ionomycin | 1 | 2008 | 4 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 16 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2008 | 10 | 0.020 |
Why?
|
| African Americans | 1 | 2011 | 353 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2008 | 61 | 0.020 |
Why?
|
| Tyrosine | 1 | 2008 | 92 | 0.020 |
Why?
|
| Vaccination | 1 | 2010 | 213 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2070 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 329 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 140 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 2007 | 3 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 553 | 0.020 |
Why?
|
| Antigens | 1 | 2007 | 68 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2007 | 71 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 585 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2007 | 17 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 136 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2007 | 16 | 0.020 |
Why?
|
| Oklahoma | 1 | 2010 | 1062 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 12 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2006 | 11 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2007 | 202 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 111 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2009 | 428 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 303 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2007 | 524 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 415 | 0.010 |
Why?
|
| Appetite Regulation | 1 | 2000 | 3 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 43 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2000 | 122 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 2430 | 0.010 |
Why?
|
| Genome | 1 | 2000 | 58 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 208 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1999 | 14 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1997 | 24 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1997 | 63 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1997 | 81 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 523 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 1201 | 0.010 |
Why?
|
| Child | 1 | 1997 | 2335 | 0.010 |
Why?
|